Impact of Inpatient Initiation of Sodium-Glucose Cotransporter-2 Inhibitors on Prescription Rates in Patients With Heart Failure With Reduced Ejection Fraction.
住院患者開始使用鈉葡萄糖共轉運子-2抑制劑對心衰患者降低射血分數處方率的影響。
Am J Cardiol 2023-10-12
Early Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Leads to a Shorter Hospital Stay in Patients With Acute Decompensated Heart Failure.
急性失代償性心衰患者早期使用鈉葡萄糖共同轉運蛋白2抑製劑可縮短住院時間。
Circ Rep 2023-09-20
Association of sodium-glucose cotransporter 2 inhibitors with post-discharge outcomes in patients with acute heart failure with type 2 diabetes: a cohort study.
與急性心衰患者的出院後結果相關的二型糖尿病患者使用鈉葡萄糖共轉運蛋白2抑制劑:一項cohort研究。
Cardiovasc Diabetol 2023-08-03
Short-term outcomes after sodium-glucose cotransporter-2 inhibitor initiation in a cohort of heart failure patients.
心衰患者中鈉葡萄糖共轉運輸蛋白-2抑制劑啟動後的短期結果。
ESC Heart Fail 2023-10-14
Outcomes Associated with Sodium-Glucose Cotransporter-2 Inhibitor Use in Acute Heart Failure Hospitalizations Complicated by AKI.
急性心衰併發腎損傷的急性心衰住院患者使用鈉葡萄糖共轉運輸蛋白-2抑製劑的相關結果。
Kidney360 2024-03-12
Early Initiation of SGLT2 Inhibitors in Acute Heart Failure: a Focus on Diuresis and Renal Protection.
急性心衰患者早期使用SGLT2抑制劑:著重利尿和腎臟保護。
Cardiovasc Drugs Ther 2023-10-12
Real-World Use and Outcomes of Sodium Glucose Cotransporter 2 Inhibitors in Adults with Diabetes and Heart Failure: A Population Level Cohort Study in Alberta, Canada.
加拿大阿爾伯塔省糖尿病與心臟衰竭成人中鈉葡萄糖共轉運輸蛋白2抑制劑的真實世界使用和結果:人口層級的 cohort 研究。
Can J Diabetes 2024-03-28